Scalper1 News
One of the biggest medical meetings of the year is this weekend, as the American Society of Hematology (ASH) convenes in Orlando, Fla., to hear about the latest attacks on some of the world’s most intractable blood cancers. Already, some abstracts of presentations released ahead of the conference have made a splash. Tiny French biotech Cellectis (CLLS) will offer details on a case study of an infant with acute lymphoblastic leukemia (ALL) who was Scalper1 News
Scalper1 News